Elite Pharmaceuticals (ELTP) Liabilities and Shareholders Equity (2011 - 2026)
Elite Pharmaceuticals (ELTP) posted Liabilities and Shareholders Equity of $139.67 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 25.4% from $111.34 million a year earlier and up 1.0% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Liabilities and Shareholders Equity came in at $138.29 million, up 43.5% from FY2025.
- Annual Liabilities and Shareholders Equity has increased for seven consecutive fiscal years, with a five-year compound annual growth rate of 39.5% (FY2021 to FY2026).
- In prior fiscal years, Elite Pharmaceuticals' Liabilities and Shareholders Equity was $96.39 million in FY2025 (+15.2%), $83.65 million in FY2024 (+104.6%), $40.9 million in FY2023 (+16.4%) and $35.15 million in FY2022 (+34.2%).
- The fiscal Q1 2027 figure stands as the highest quarterly Liabilities and Shareholders Equity in data going back to fiscal Q4 2011.
- On a year-over-year basis, Liabilities and Shareholders Equity has increased in each of the last 12 quarters, with growth averaging 28.7% over the last eight quarters.
- The year-over-year growth in Liabilities and Shareholders Equity has ranged between 10.9% (fiscal Q2 2022) and 104.6% (fiscal Q4 2024) over the last five years.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior fiscal quarters was $138.29 million (Q4 2026), $126.41 million (Q3 2026) and $117.25 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Elite Pharmaceuticals | 268.12 Mn | 149.80 Mn | 13.51 Mn | 139.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 139.67 Mn |
| Mar 31, 2026 | 138.29 Mn |
| Dec 31, 2025 | 126.41 Mn |
| Sep 30, 2025 | 117.25 Mn |
| Jun 30, 2025 | 111.34 Mn |
| Mar 31, 2025 | 96.39 Mn |
| Dec 31, 2024 | 90.76 Mn |
| Sep 30, 2024 | 88.20 Mn |
| Jun 30, 2024 | 87.85 Mn |
| Mar 31, 2024 | 83.65 Mn |
| Dec 31, 2023 | 74.70 Mn |
| Sep 30, 2023 | 70.72 Mn |
| Jun 30, 2023 | 46.50 Mn |
| Mar 31, 2023 | 40.90 Mn |
| Dec 31, 2022 | 52.72 Mn |
| Sep 30, 2022 | 50.34 Mn |
| Mar 31, 2022 | 35.15 Mn |
| Dec 31, 2021 | 31.95 Mn |
| Sep 30, 2021 | 30.62 Mn |
| Jun 30, 2021 | 29.99 Mn |
API Access
Elite Pharmaceuticals Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();